Eliquis Vs. Nattokinase for a female patient aged 75 (an AI-powered real world drug study)

Summary:

This is a personalized comparison of Eliquis, Nattokinase for a woman aged 75. The study is created by eHealthMe based on reports from the FDA and eHealthme.


On Jun, 12, 2026

29,000 females aged 75 (±5) who take Eliquis, Nattokinase and have adverse effects are studied.


Number of reports submitted per year:

Eliquis, Nattokinase for a female patient aged 75.

Information of the patient in this study:

  • Age: 75
  • Gender: female

What are the drugs?

What is the reason to compare the drugs?


eHealthMe real world results:

Most common side effects:

Eliquis:

  1. Death
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Diarrhoea
  5. Fall
  6. Nausea (feeling of having an urge to vomit)
  7. Dizziness
  8. Asthenia (weakness)
  9. Headache (pain in head)
  10. Cerebrovascular Accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

Nattokinase:

  1. Arthralgia (joint pain)
  2. Back Pain
  3. Fatigue (feeling of tiredness)
  4. Pain In Extremity
  5. Pain In Jaw
  6. Osteitis (a general term for inflammation of bone)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Limb Discomfort (discomfort in leg)
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Open Wound

Most common side effects experienced by people in long term (1+ years) use:

Eliquis:

  1. Fall
  2. Anaemia (lack of blood)
  3. Cerebral Haemorrhage (bleeding within the brain)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Fatigue (feeling of tiredness)
  6. Haemorrhage (bleeding)
  7. Dizziness
  8. Asthenia (weakness)
  9. Dyspnoea (difficult or laboured respiration)
  10. Epistaxis (bleed from the nose)

Nattokinase:

  1. Muscle Aches (muscle pain)

Drug effectiveness:

Eliquis:

  • not at all: 2.76 %
  • somewhat: 9.39 %
  • moderate: 26.52 %
  • high: 46.41 %
  • very high: 14.92 %

Nattokinase:

  • not at all: 0 %
  • somewhat: 0 %
  • moderate: 50 %
  • high: 50 %
  • very high: 0 %



How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related studies

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: